Ampuero J, Romero-Gomez M (2015) Hepatitis C virus: current and evolving treatments for genotypes 2 and 3. Gastroenterol Clin N Am 44(4):845–857
Article
Google Scholar
Angelo AL, Cavalcante LN, Abe-Sandes K, Machado TB, Lemaire DC, Malta F et al (2013) Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B. Clinics (Sao Paulo) 68(10):1325–1332
Article
Google Scholar
Anwar MI, Rahman M, Hassan MU, Iqbal M (2013) Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J 10:351
Article
PubMed
PubMed Central
Google Scholar
Aziz H, Raza A, Irfan J (2016) Optimum predictors of therapeutic outcome in HCV patients in Pakistan. J Med Virol 88(1):100–108
Article
CAS
PubMed
Google Scholar
Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, Young SN et al (2012) Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 36(2):239–250
Article
CAS
PubMed
PubMed Central
Google Scholar
Collins AS, Ahmed S, Napoletano S, Schroeder M, Johnston JA, Hegarty JE et al (2014) Hepatitis C virus (HCV)-induced suppressor of cytokine signaling (SOCS) 3 regulates proinflammatory TNF-α responses. J Leukoc Biol 96(2):255–263
Article
PubMed
Google Scholar
Fallahi P, Ferri C, Ferrari SM, Corrado A, Sansonno D, Antonelli A (2012) Cytokines and HCV-related disorders. Clin Dev Immunol 2012:468107
Article
PubMed
PubMed Central
Google Scholar
Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S et al (2011) Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J Virol 85(12):5986–5994
Article
CAS
PubMed
PubMed Central
Google Scholar
Goossens N, Negro F (2014) Is genotype 3 of the hepatitis C virus the new villain? Hepatology 59(6):2403–2412
Article
CAS
PubMed
Google Scholar
Hamdi N, El-Akel W, El-Serafy M, Esmat G, Sarrazin C, Abdelaziz AI (2012) Transcriptional response of MxA, PKR and SOCS3 to interferon-based therapy in HCV genotype 4-infected patients and contribution of p53 to host antiviral response. Intervirology 55(3):210–218
Article
CAS
PubMed
Google Scholar
Jablonowska E, Wojcik K, Koslinska-Berkan E, Szymanska B, Omulecka A, Piekarska A (2014) Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection. Arch Virol 159(6):1365–1371
Article
CAS
PubMed
Google Scholar
Kim KA, Lin W, Tai AW, Shao RX, Weinberg E, De Sa Borges CB et al (2009) Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection. J Hepatol 50(4):705–711
Article
PubMed
PubMed Central
Google Scholar
Krebs DL, Hilton DJ (2001) SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19(5):378–387
Article
CAS
PubMed
Google Scholar
Li Y, Zhang Q, Liu Y, Luo Z, Kang L, Qu J et al (2012) Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways. J Virol 86(23):12531–12543
Article
CAS
PubMed
PubMed Central
Google Scholar
Luedde T, Wuestefeld T, Trautwein C (2001) A new player in the team: SOCS-3 socks it to cytokine signaling in the regenerating liver. Hepatology 34(6):1254–1256
Article
CAS
PubMed
Google Scholar
Miyoshi H, Fujie H, Shintani Y, Tsutsumi T, Shinzawa S, Makuuchi M et al (2005) Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. J Hepatol 43(5):757–763
Article
CAS
PubMed
Google Scholar
Pascarella S, Clement S, Dill MT, Conzelmann S, Lagging M, Missale G et al (2013) Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis C. Liver Int 33(1):94–103
Article
CAS
PubMed
Google Scholar
Pawelec G, Hirokawa K, Fulop T (2001) Altered T cell signalling in ageing. Mech Ageing Dev 122(14):1613–1637
Article
CAS
PubMed
Google Scholar
Persico M, Capasso M, Persico E, Svelto M, Russo R, Spano D et al (2007) Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: insulin resistance and response to antiviral therapy. Hepatology 46(4):1009–1015
Article
CAS
PubMed
Google Scholar
Persico M, Capasso M, Russo R, Persico E, Croce L, Tiribelli C et al (2008) Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C. Gut 57(4):507–515
Article
CAS
PubMed
Google Scholar
Rana D, Chawla Y, Arora SK (2013) Success of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cells. Indian J Med Res 138(5):766–778
CAS
PubMed
PubMed Central
Google Scholar
Ryan JD, Altamura S, Devitt E, Mullins S, Lawless MW, Muckenthaler MU et al (2012) Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C. Hepatology 56(2):492–500
Article
CAS
PubMed
Google Scholar
Seki E, Kondo Y, Iimuro Y, Naka T, Son G, Kishimoto T et al (2008) Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings. J Hepatol 48(2):237–245
Article
CAS
PubMed
Google Scholar
Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY et al (2010) Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J Virol 84(12):6060–6069
Article
CAS
PubMed
PubMed Central
Google Scholar
Shao RX, Zhang L, Hong Z, Goto K, Cheng D, Chen WC et al (2013) SOCS1 abrogates IFN’s antiviral effect on hepatitis C virus replication. Antivir Res 97(2):101–107
Article
CAS
PubMed
Google Scholar
Stevenson NJ, Bourke NM, Ryan EJ, Binder M, Fanning L, Johnston JA et al (2013) Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett 587(10):1571–1578
Article
CAS
PubMed
Google Scholar
Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194(10):1395–1406
Article
CAS
PubMed
PubMed Central
Google Scholar
Timm JA, Thoman ML (1999) Maturation of CD4 + lymphocytes in the aged microenvironment results in a memory-enriched population. J Immunol 162(2):711–717
CAS
PubMed
Google Scholar
Tsubota A, Fujise K, Namiki Y, Tada N (2011) Peginterferon and ribavirin treatment for hepatitis C virus infection. World J Gastroenterol 17(4):419–432
Article
CAS
PubMed
PubMed Central
Google Scholar
Walsh MJ, Jonsson JR, Richardson MM, Lipka GM, Purdie DM, Clouston AD et al (2006) Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut 55(4):529–535
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao LJ, He SF, Wang W, Ren H, Qi ZT (2016) Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus. Cytokine 80:48–55
Article
CAS
PubMed
Google Scholar